Research programme: non-opioid therapeutics - PixarBioAlternative Names: NeuroRelease; NeuroRelease SCI; NR-SCI - PixarBio; NR-TN - PixarBio
Latest Information Update: 10 Jan 2017
At a glance
- Originator PixarBio Corporation
- Class Non-opioid analgesics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Pain
- Research Epilepsy; Parkinson's disease; Spinal cord injuries; Trigeminal neuralgia